Macquarie Group LTD Adma Biologics, Inc. Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
A detailed history of Macquarie Group LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 1,138,323 shares of ADMA stock, worth $21.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,138,323
Previous 182,333
524.31%
Holding current value
$21.8 Million
Previous $2.04 Million
1016.54%
% of portfolio
0.03%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ADMA
# of Institutions
318Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$357 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$347 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$249 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$241 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$165 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.76B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...